An AI-powered tool designed for prostate cancer detection, QP-Prostate by Quibim, has been selected for rollout across seven NHS hospitals in England.
This two-year initiative, announced on July 9, 2025, aims to enhance early diagnosis…
What You Should Know:
– CoreViva, a physician-founded and physician-backed whole-body MRI clinic, today announced the opening of its flagship location in Newport Beach, now open for patient bookings.
– Founded by radiologists Dr. A. Alexander…
Continue Reading
Traditional tuberculosis (TB) screening involves radiologists manually reviewing chest X-rays (CXR), which is time-consuming, error-prone, and limited by workforce shortages. Our AI model, AIRIS-TB (AI Radiology In Screening TB), aims to address these challenges…
Continue Reading
[embedded content]
What You Should Know:
– Robovision Healthcare and the Netherlands Cancer Institute (NKI) have unveiled a pioneering AI solution, BrainMets AI, capable of detecting brain metastatic disease with unprecedented precision. The breakthrough research, published…
Continue Reading
The Soliton IT and xWave team celebrating their new partnership (Credit: xWave Technologies)
Health tech firm Soliton IT and Irish start-up xWave Technologies have integrated their solutions with the aim of improving NHS radiology…
Continue Reading
Prostate cancer (PCa) is one of the most common types of cancer, seriously affecting adult male health. Accurate and automated PCa segmentation is essential for radiologists to confirm the location of cancer, evaluate its…
Continue Reading
For a long time, the promise that artificial intelligence offered to radiology has been especially exciting. In this video, Thomas Bertinotti, Chief Product Officer and VP of Business Operations USA at Therapixel, describes how…
Continue Reading
(L to R) Mitchell O’Gorman, chief executive of xWave Technologies, and Catherine Walsh, associate director of the Greater Manchester Imaging Network (Credit: Greater Manchester Imaging Network)
Irish health tech start-up xWave Technologies is partnering…
Continue Reading
Portal Access, an oncology-focused medical device startup, closed a $7 million Series A financing round.The company said that more than 80% of the round was led by U.S. physician investors, including oncologists, interventional radiologists,…
Continue Reading
Preoperative detection of pT3a invasion in non-metastatic renal cell carcinoma (RCC) remains challenging with CT. This study developed and validated radiomic models using preoperative CT to identify pT3a invasions. Six models were trained and…
Continue Reading
